SUMMARY
Current human pluripotent stem cells lack the transcription factor circuitry that governs the ground state of mouse embryonic stem cells (ESC). Here, we report that short-term expression of two components, NANOG and KLF2, is sufficient to ignite other elements of the network and reset the human pluripotent state. Inhibition of ERK and protein kinase C sustains a transgene-independent rewired state. Reset cells self-renew continuously without ERK signaling, are phenotypically stable, and are karyotypically intact. They differentiate in vitro and form teratomas in vivo. Metabolism is reprogrammed with activation of mitochondrial respiration as in ESC. DNA methylation is dramatically reduced and transcriptome state is globally realigned across multiple cell lines. Depletion of ground-state transcription factors, TFCP2L1 or KLF4, has marginal impact on conventional human pluripotent stem cells but collapses the reset state. These findings demonstrate feasibility of installing and propagating functional control circuitry for ground-state pluripotency in human cells.
INTRODUCTION
Human pluripotent stem cells (PSC), derived from supernumerary embryos or by molecular reprogramming, show several distinguishing characteristics compared with paradigmatic mouse embryonic stem cells (ESC). Originally regarded as inconsequential species-specific features, increasing evidence suggests discrete developmental identities. Notably, derivation of postimplantation epiblast stem cells (EpiSC) (Brons et al., 2007; Tesar et al., 2007) shows that alternative pluripotent stem cells can be obtained from mice. EpiSC are related to primitive streak-stage late epiblast (Kojima et al., 2014; Tsakiridis et al., 2014) . The terminology naive and primed was introduced to describe early and late phases of epiblast ontogeny and respective ESC and EpiSC derivatives . Human PSC are considered more related to primed EpiSCs than to naive ESC.
Mouse ESC self-renewal is favored by blockade of mitogenactivated protein kinase (Erk) signaling and is stimulated by the cytokine leukemia inhibitory factor (LIF) . Combining two inhibitors (2i) of the Erk pathway and of glycogen synthase kinase-3 with LIF (2iL) provides a defined culture system that is effective for all strains of mouse and rat tested, supporting efficient ESC derivation and clonal expansion from dissociated cells (Boroviak et al., 2014; Ying et al., 2008) . This serum-and growth-factor-free formulation is also selective; most cell types, including EpiSC and human PSC, differentiate or die in 2iL alone. The stability and relative homogeneity of ESC in 2iL (Wray et al., 2010 ) is postulated to represent a developmental ground state closely reflective of the newly formed epiblast in the mature blastocyst ). In contrast, EpiSC and human PSC are heterogeneous between and within cell lines (Kojima et al., 2014; Tsakiridis et al., 2014) and passage poorly when dissociated, resulting in low cloning efficiency. They are unresponsive to LIF but rely on growth factors, specifically fibroblast growth factor (FGF) and TGFb/activin (Amit et al., 2000; Vallier et al., 2005) .
The transcriptional regulators Oct4 and Sox2 constitute the pillar of pluripotency through all its phases. These factors are essential but are not restricted to, nor sufficient for, the ESC ground state. A select group of regulators present in the preimplantation epiblast and ESC interconnect with Oct4/Sox2 to confer and sustain naive status. Foremost among these are Nanog, Klf2, Klf4, Esrrb, and Tfcp2l1 (Dunn et al., 2014; Ivanova et al., 2006; Martello et al., 2013; Niwa et al., 2009; Ye et al., 2013) . Apart from Nanog, these factors are expressed at very low levels or are absent from EpiSC and human PSC. Strikingly, however, transfection of EpiSC with a single component in conjunction with transfer to 2iL can ignite the entire circuitry and reset the ESC ground state Hanna et al., 2009; Silva et al., 2009) .
Conversion of mouse EpiSCs to ESC may provide a paradigm for generation of human ground-state PSC. Early trials (Hanna et al., 2010; Wang et al., 2011) noted ESC-like morphology, but cells appeared unstable. More recently, complex culture formulations have been proposed to allow propagation of human PSC with altered characteristics (Chan et al., 2013; Gafni et al., 2013; Ware et al., 2014) , but these cells remain dependent on FGF, TGFb, and/or serum replacement factors and lack evidence for rewiring of transcriptional control circuitry. We therefore investigated further the generation and stabilization of human cells with phenotypic features and transcription factor governance characteristic of ground-state pluripotency.
RESULTS

NANOG and KLF2 Reset the Human PSC Phenotype
Expression of Nanog or Klf2 converts mouse EpiSC to groundstate ESC in 2iL Silva et al., 2009) . We tested the effect of this pair of factors in human embryo-derived H9 cells. We introduced doxycycline (DOX)-inducible KLF2 and NANOG/Venus constructs along with an rtTA vector. Transfectants were selected in conventional PSC culture medium (FGF/ KSR) without DOX. Cultures were replated prior to addition of DOX. DOX-induced cells differentiated or died in FGF/KSR. In contrast, in 2iL undifferentiated cells persisted and formed colonies that could readily be expanded. These cells were positive for Venus, indicating robust transgene induction, and displayed the tightly packed domed appearance typical of mouse ESC in 2iL ( Figure 1A ). Cultures could be propagated continuously by enzymatic dissociation to single cells without requirement for ROCKi (Watanabe et al., 2007) . On withdrawal of DOX, however, cultures degenerated unless transferred into FGF/KSR when they reverted to conventional flat PSC colony morphology and sensitivity to dissociation. Cells could be cycled between these two exclusive conditions ( Figure 1A ).
We investigated candidate pathways for the ability to support propagation in 2iL upon DOX withdrawal. Addition of the protein kinase C (PKC) inhibitor Gö 6983 (5 mM), which suppresses mouse ES cell differentiation (Dutta et al., 2011) , sustained compact refractile colonies lacking Venus ( Figure 1B ). These cultures expressed OCT4 ( Figure S1 available online) and expanded continuously, although proliferation was reduced and morphology less consistent compared to cells in DOX. Moderating GSK3 inhibition improves rat ES cell culture (Chen et al., 2013; Meek et al., 2013) , and we also observed that combination of Gö 6983 with GSK3 inhibitor CH is unfavorable for mouse ESC propagation (A.S., unpublished data). Colony morphology in the absence of DOX was improved without CH, but growth rate was reduced. An intermediate concentration of 1 mM CH restored growth while maintaining morphology (Figure 1C) . Henceforth cells were maintained in titrated 2i with LIF and Gö 6983 (t2iL+Gö ). Undifferentiated colonies formed from dissociated cells without ROCKi ( Figure 1D ). Immunoblotting confirmed that Erk signaling was fully blocked ( Figure S1B ). Colony formation was not suppressed by inhibitors of TGF-b/activin or FGF receptors ( Figures 1E and S1C ).
We induced conversion using different embryo-derived and induced PSC (Table S1 ) and in all cases obtained abundant tightly packed colonies with DOX. On DOX withdrawal and switch to t2iL+Gö , cultures initially became heterogeneous. Tightly packed colonies dominated after two to four passages and thereafter were readily maintained over multiple passages by single-cell dissociation every 4-6 days and replating at a split ratio of 1:3 to 1:5. Independent cultures were propagated for more than 20 passages (4 months) with no deterioration in morphology or doubling time ( Figure 1F and Table S1 ). Metaphase counts and array analyses ( Figure 1G and Table S1 ) confirmed genetic integrity of different lines over multiple passages.
Following DOX withdrawal, transgene products were undetectable by fluorescence or qRT-PCR (Figures S1D and S1E). We profiled cultures in t2iL+Gö for the suite of transcription factors diagnostic of, and functionally implicated in, the ESC ground state (Dunn et al., 2014) . Compared with no or minimal expression in conventional PSC, all factors were substantially upregulated apart from ESRRB (Figures 1H and S1E) . Protein expression was confirmed by immunostaining and immunoblotting ( Figures 1I, 1J , and S1F). TFE3 was nuclear compared with cytoplasmic localization in conventional PSC, as shown for mouse naive versus primed cells (Betschinger et al., 2013) .
The preceding experiments were performed on feeders. From observations with mouse ESC, we realized that, without buffering by feeders, Gö was potentially toxic. We therefore reduced Gö to 2 mM and also added ROCKi prior to passaging. In these conditions, reset cells could form undifferentiated colonies on Matrigel or laminin 511-E8 (Nakagawa et al., 2014) (Figure 1K ). On both substrates, cells could be expanded, albeit more slowly on laminin, with retained expression of ground-state pluripotency factors ( Figure 1L ).
These observations indicate that NANOG and KLF2 can reset self-renewal requirements and transcription factor complement in human PSC and, furthermore, that this rewired state may be rendered independent of transgene expression by fine-tuning 2iL in combination with the PKC inhibitor Gö 6983.
Differentiation Competence
To test whether reset PSC are capable of germ-layer specification, we generated embryoid bodies directly from reset cells. Embryoid bodies were harvested after 5 or 10 days and analyzed by qRT-PCR. Transcripts diagnostic of the three germ layers were upregulated (Figure 2A ). Differentiation capacity was tested further by grafting to NOD/SCID mice. Cells transplanted directly from t2iL+Gö formed teratomas by 12 weeks that contained well-differentiated regions of neuroepithelium, cartilage, and digestive tract ( Figure 2B ). On transfer to FGF/KSR, reset cells adopted a conventional PSC phenotype ( Figure 2C ) accompanied by downregulation of ground-state pluripotency factors ( Figure 2D ). After culture for two passages in FGF/KSR, cells lost ability to form colonies in t2iL+Gö , confirming a stable change in cell state ( Figure 2E ). We reasoned that reset cells could be channeled into adherent differentiation by exposure to FGF/KSR and application of protocols developed for conventional PSC. Cells exchanged into FGF/ KSR for a few days responded to activin and Wnt3A (Kroon et al., 2008) by differentiation into definitive endoderm ( Figure 2F ). Conversely, treatment with Noggin and SB431542 resulted in neuronal cells with dendritic processes ( Figure 2G ). Cells changed into FGF/KSR and aggregated, upregulated cardiac markers ( Figure 2H ), and formed outgrowths with beating foci.
We conclude that reset cells can progress via a primed state into germ-layer differentiation.
Mitochondrial and Metabolic Adjustment ESC utilize oxidative phosphorylation, whereas EpiSC/human PSC are almost entirely glycolytic with very low mitochondrial respiration capacity (Zhou et al., 2012) . We measured basal oxygen consumption rate (OCR) and found that it was substantially higher in reset cells than in conventional PSC ( Figure 3A ). Higher electron transport chain activity in reset cells was evidenced by a greater OCR increase in response to the mitochondrial uncoupler FCCP ( Figure 3A ). Reset cells also displayed intense staining with tetramethylrhodamine methyl ester (TMRE), indicative of mitochondrial membrane depolarization ( Figure 3B ). Furthermore, the complex IV cytochrome c oxidase (COX) gene family displayed higher expression in reset cells than conventional PSC for 14 out of 17 genes ( Figure S2A ), similar to findings for ESC and EpiSC (Zhou et al., 2012) .
We examined functional consequences of altered metabolic properties by culture in 2-deoxyglucose to inhibit glycolysis and in reduced concentrations of glucose to increase dependency on mitochondrial respiration. Unlike conventional PSC, reset cells formed undifferentiated colonies in the presence of 2-deoxyglucose ( Figure 3C ) or as low as 0.2 mM glucose ( Figure S2B ).
These data indicate that resetting human PSC is accompanied by a profound mitochondrial activation and metabolic realignment.
Epigenetic Reorganization
Global DNA hypomethylation is a feature of early embryo cells that is recapitulated in ESC cultured in 2i in contrast to hypermethylation in EpiSCs (Ficz et al., 2013; Habibi et al., 2013; Leitch et al., 2013) . Immunofluorescence staining for 5-methylcytosine (5mC) was notably weaker in reset cells than conventional cultures ( Figure 4A ). Mass spectrometric quantification confirmed a major reduction in total 5mC and also in 5-hydroxymethylcytosine ( Figure 4B ). Bisulfite sequencing (BS-seq) at 8.83 genome coverage ( Figure S3A ) substantiated more than 50% loss of CpG methylation genome wide ( Figure 4C ), along with lower non-CpG methylation. Demethylation was substantial in most genomic contexts ( Figure 4D) . A representative genomic interval shows hypomethylation across the SOX2 locus ( Figure S3B ). A minor subset of genes showed retained or even increased methylation.
The X chromosome in reset cells exhibited specific reduction in intermediate levels of CGI demethylation ( Figure 4E ). Intermediate levels are likely to reflect methylation of a proportion of Xlinked CGIs in conventional PSC. Consistent with epigenetic erasure of the X chromosome, we observed that foci of histone 3 lysine 27 trimethylation (H3K27me3) were almost entirely lacking in reset XX cells ( Figure 4F ), although as previously described (Silva et al., 2008; Tomoda et al., 2012) , this modification was already absent in many of the parental cells. Notably, however, upon transfer of reset cells to KSR/FGF culture conditions, foci of H3K27me3 appeared in the majority of cells within two passages. We also examined trimethylation of histone 3 lysine 9 (H3K9me3) associated with gene silencing. Reset cells exhibit much lower levels of this feature compared with conventional human PSC, recapitulating the difference observed between mouse ESC and EpiSC (Figures 4G, S3C, and S3D) .
These data indicate that resetting the human PSC state is accompanied by profound epigenetic deconstruction. Local demethylation has been described for purported human naive PSC (Gafni et al., 2013) , but no evidence has been provided for global changes or for demethylation of the X chromosome. The global reduction in DNA methylation in reset cells is similar in magnitude to hypomethylation in mouse ground-state ESC and in line with the demethylated status reported for the human inner cell mass (ICM) (Guo et al., 2014; Smith et al., 2014) .
Transcriptome Reconfiguration
We assessed the transcriptional state of conventional human PSC, reset cells, and mouse ESC by RNA-seq. Multiple independent conventional cultures of H9 and induced PSC were analyzed alongside reset counterparts. Clustering by principal component analysis revealed mutually exclusive groups of conventional human PSC and reset cells, with distinct clusters of mouse ESC and human reset cells ( Figure 5A ). Much of the variation (24%) is captured in the first principal component, indicating significant correspondence between reset cells and human blastocyst ICM (Yan et al., 2013) . In contrast, explanted human ICM cells propagated in FGF/KSR adopt similar expression profiles to conventional PSC cultures. Divergence with respect to the second principal component is not unexpected given that ESC bear closest resemblance to epiblast cells in the late blastocyst rather than immature ICM cells (Boroviak et al., 2014) . Inspection of genes contributing to the first two principal components confirms the influence of pluripotency factors in reset Figure 5B ). In contrast to conventional PSC, robust expression was observed of ground-state pluripotency regulators in both reset cells and ground-state ESC. This is accompanied by repression of lineage-specific genes. Reset cells and ESC form a distinct cluster characterized by the robust expression of naive markers including NANOG, KLF4, and TFCP2L1. In contrast, PSC cultured in conventional media or the 3iL formulation (Chan et al., 2013) show prominent expression of lineage markers such as AFP, Brachyury, and EOMES. Gene ontology analysis of differentially expressed genes indicated enrichment of categories representative of developmental pathways (Table S2) .
We additionally compared reset and conventional PSC with NHSM or 3iL cells purported to have undergone conversion to a naive state (Chan et al., 2013; Gafni et al., 2013) . To facilitate direct comparison, samples were hybridized to the identical microarray platform used in Gafni et al. (2013) . We profiled an extended panel of samples, including reset cells and standard counterparts from H9 and two independent iPS cell lines, in addition to those profiled by RNA-seq above. Data from each study were normalized to conventional human embryo-derived PSC to integrate microarray and RNA-seq data sets. A significant departure from the conventional state was not apparent for cell lines propagated in alternate culture regimes, suggesting that they have not fundamentally changed from standard human PSC ( Figure 5A ). Analysis of data from Gafni et al. (2013) wide variation across individual lines but relatively minor divergence from other conventional human PSC cultures ( Figures  S5A and S5B ).
Reset cells display expression patterns characteristic of ground-state ESC, in contrast to NHSM cultures where, remarkably, the expression of key pluripotency factors is often downregulated or abolished ( Figure 5C ). The inverse trend was evident when examining a range of lineage-specific genes, which are heavily downregulated in ESC and reset cells but display spurious expression in NHSM and 3iL cultures ( Figure 5D ). A number of chromatin modifiers also exhibited expression more comparable to mouse ESC for reset cells than for alternative cultures, with NHSM cells lacking expression of important epigenetic regulators such as MLL3, NCOA3, and TETs ( Figure S5C ). In line with the observed DNA hypomethylation in reset cells, transcripts for DNMT3B were greatly reduced and for DNMT3L increased (Neri et al., 2013) .
To evaluate whether the ground-state pluripotency factors defined in mouse and upregulated in human reset cells are indeed features of human naive pluripotency, we examined two key factors, TFCP2L1 and KLF4, in human embryos. Supernumerary embryos were thawed and cultured to the expanded blastocyst stage for immunostaining (Roode et al., 2012) . We detected KLF4 exclusively in the ICM ( Figure 5E ). TFCP2L1 signal was unambiguous in a subset of the KLF4-positive cells within the ICM. Thus, the ICM in the mature human blastocyst contains cells double positive for KLF4 and TFCP2L1 protein. Neither factor is upregulated in previously described human PSC (Figure 5C ), but they are coexpressed along with NANOG in reset cells ( Figure 5F ), as in mouse ESC.
Executive Operation of Ground-State Transcription Factor Circuitry
To determine whether the ground-state transcription factor circuitry is functional in reset cells, we tested dependency on specific factors using RNAi. siRNA against nonessential naive pluripotency markers REX1 (ZFP42) and STELLA (DPPA3) did not impair colony formation by either reset or conventional PSC ( Figure 6A ). In contrast, knockdown of KLF4 or TFCP2L1 markedly reduced colony formation by reset cells but had little effect on conventional cultures. We then used shRNA for constitutive knockdown ( Figure S6A ). When NANOG and KLF2 transgenes were maintained with DOX, TFCP2L1 or KLF4 knockdown was tolerated but cells showed reduced colony formation (Figures 6B and 6C) . After DOX withdrawal, colony formation was largely abolished by knockdown in t2iL+Gö but was unaffected in FGF/KSR/ROCKi, where cells adopted flattened conventional PSC morphology ( Figures 6C and S6B) . KLF4 shRNA targets the 3 0 UTR, and expression of human KLF4 fully restored colony formation ( Figure 6D ). TFCP2L1 shRNA targets the coding sequence, but the knockdown phenotype was partially rescued by mouse Tfcp2l1 (Figure S6C ).
Mouse ESC can withstand Tfcp2l1 depletion due to compensation by Esrrb (Martello et al., 2013) . Reset human cells may be sensitized due to weak expression of ESRRB. We therefore tested whether transgenic ESRRB can rescue colony formation upon TFCP2L1 knockdown. Indeed, ESRRB expression rendered reset cells resistant to TFCP2L1 shRNA such that they formed multiple colonies in t2iL+Gö that had refractile domed morphology and could be expanded after passaging ( Figure 6E ).
These findings indicate that the self-renewal of reset human cells, but not conventional PSC, is strongly reliant on TFCP2L1 and KLF4 and furthermore point to conserved functionality of ground-state transcription factors between mouse and human, even though individual factor expression may be altered.
As a potential functional test of naive epiblast identity, we introduced reset cells into mouse preimplantation embryos and monitored development in vitro. We first used fibroblastderived induced PSC stably transfected with CAG-Cherry before and after resetting. After morula aggregation using conventional iPSC, we did not detect any Cherry-positive cells in 37 blastocysts. In contrast, reset cells contributed to the ICM in 6 of 42 blastocysts and in some cases appeared well integrated in the epiblast compartment ( Figure 6F ). We repeated this test on reset cells harboring a GFP reporter and found GFP-positive cells within the ICM/epiblast in 8 of 49 blastocysts. We also assessed whether reset cells could be incorporated into the ICM by blastocyst injection. Injected embryos were cultured for 72 hr to allow hatching and primary ICM outgrowth. Of 32 injected embryos, 9 showed GFP-positive cells within the mature ICM/epiblast ( Figure 6G ). In contrast, none of 17 blastocysts injected with conventional Shef6 PSC showed colonization.
These data suggest that human reset cells are sufficiently similar to mouse naive cells to allow incorporation into the ICM and preimplantation epiblast.
Transient Transgenesis and Stable Resetting
We investigated the time span for resetting and found that 8 days of induction was sufficient ( Figure 7A ). Equivalent expression should be achievable by transient transgenesis. To identify and select reset cells, we exploited the EOS construct (A) PCA of RNA-seq and microarray data from this study with RNA-seq data from Chan et al. (2013) , microarray data from Gafni et al. (2013) , and single-cell RNAseq data from Yan et al. (2013) . Samples generated in this study were additionally hybridized to the identical array platform used by Gafni et al. (2013) to facilitate direct comparison. Data were normalized to conventional PSC in each study. Similar clustering is apparent using RNA-seq data alone ( Figure S4B ), discounting the influence of platform differences.
(legend continued on next page) (Hotta et al., 2009 ) incorporating the mouse Oct4 distal enhancer active in naive, but not primed, pluripotent cells. We transfected H9 and Shef6 cells bearing an integrated PB-EOS-GFP/puro R construct with constitutive expression plasmids for NANOG and KLF2 ( Figure 7B) . In pilot studies, we observed that CH appeared inhibitory to the resetting process and that addition of the FGF receptor inhibitor PD17 might favor resetting. Accordingly, 2 days after transfection, medium was switched from FGF/KSR to N2B27 supplemented with PD17, PD03, and LIF. At day 4, cells were retransfected, and on day 8, medium was changed to t2iL+Gö . From day 12, several GFP-positive clusters of cells became visible and puromycin selection commenced. Cultures were heterogeneous and were passaged four times before discrete colonies were picked ( Figure 7C ). Seven of nine cultures showed no detectable transgene at single-copy resolution ( Figure 7D ). They were indistinguishable in morphology from cultures in which transgenes were detected or from reset cells generated with inducible transgenes. qRT-PCR and immunostaining confirmed sustained expression of ground-state pluripotency factors (Figures 7E and 7F) . Passaging time was comparable to reset cells generated via inducible transgene expression, as was colony formation efficiency of 5%-10% without ROCKi. Colony formation in the presence of A83-01 ( Figure 7G ) demonstrated independence from activin/nodal, unlike other human PSC. Furthermore, knockdown of TFCP2L1 or KLF4 significantly impaired colony formation ( Figure 7H ), indicating dependency on ground-state transcription factors.
We conclude that the reset state can be generated without permanent genetic modification.
DISCUSSION
The postulate that a self-renewing ground state similar to rodent ESC may pertain to primates is contentious. Our findings indicate that anticipated ground-state properties may be instated in human cells following short-term expression of NANOG and KLF2 transgenes. The resulting cells can be perpetuated in defined medium lacking serum products or growth factors. Feeders support attachment and growth of reset cells but are dispensable. Reset human stem cells show global changes in DNA methylation and transcription suggestive of a more primitive state. They also display altered metabolism with increased mitochondrial respiration. This constellation of features distinguishes reset cells from previous embryo-derived or induced human PSC and aligns them closer to ground-state mouse ESC. Most significantly, the unique transcription factor circuit essential for mouse ESC identity, self-renewal and pluripotency, is functionally operative in sustaining the reset human pluripotent state.
Previous claims of putative naive human PSC (Chan et al., 2013; Gafni et al., 2013; Ware et al., 2014) have employed culture media with an incoherent array of growth factors and inhibitors. One possibility is that such compound conditions may select for propagation of heterogeneous cultures comprising cells co-habiting in different phases of pluripotency, as described for mouse EpiSCs (Bernemann et al., 2011; Tsakiridis et al., 2014) . Lack of enrichment for naive pluripotency factors and expression of mixed lineage markers ( Figures 5C and 5D) are consistent with such an explanation.
While this study was in revision, Theunissen et al. (2014) reported that PSC cultured in a cocktail of six kinase inhibitors plus LIF and activin (6i/L/A) on feeders expressed naive features. We incorporated their data into the transcriptome meta-analysis. Use of an alternative microarray platform precludes quantitative comparison of individual genes, but PCA reveals that 6i/L/A cells are globally well separated from previously described PSC while forming a distinct cluster from reset cells ( Figure S7A ). Upregulation of naive markers and downregulation of lineage markers appears comparable to reset cells, but some differences are apparent in expression of epigenetic modifiers ( Figure S7B ). Notably, methylation regulators DNMT3a and TET1 change in opposite directions. Methylome status is not described by Theunissen et al. (2014) , but they report X chromosome inactivation, in contrast to reset cells. Both X chromosomes are active in the human ICM (Okamoto et al., 2011) , and the timing of inactivation is uncertain. Epiblast development is more protracted in primates than in rodents, raising the possibility that differences between reset and 6i/L/A cells may reflect successive phases of pluripotency.
Independence from Erk signaling is a hallmark of rodent naive cells that is conserved in human preimplantation epiblast (Roode et al., 2012) . We used 1 mM PD03 to ensure full inhibition of the Erk pathway. In contrast, GSK3 inhibition is only partial and differs between mouse and human cells. This may reflect the balance between relief of TCF3 repressor function and activation of canonical TCF/LEF factors (Chen et al., 2013) . Moreover, in mouse ESC, GSK3 inhibition acts mainly through derepression of Esrrb (Martello et al., 2013) , but ESRRB is weakly expressed in reset human PSC. Poor conservation of a genomic interval in which NANOG, OCT4, SOX2, and TCF3 bind mouse Esrrb may underlie this lack of expression ( Figure S8 ). ESRRB is a potent self-renewal factor in ESC (Festuccia et al., 2012; Martello et al., 2012) , and its noninduction may explain the insufficiency of 2iL for human cells. Gö 6983 is a broad specificity PKC inhibitor that facilitates mouse ESC self-renewal (Dutta et al., 2011) . Mutation of atypical PKC iota largely recapitulates this effect in ESC (Leeb et al., 2014) , whereas knockdown of aPKC iota in reset cells enhances propagation in t2iL without Gö ( Figure S9 ). The mechanism downstream of aPKC inhibition remains to be elucidated, but we speculate that differentiation may be inhibited by interfering with acquisition of epithelial polarity, an essential feature of postimplantation epiblast. On transfer to FGF/KSR, reset cells flatten and progressively adopt typical human PSC appearance and growth factor dependence. This process resembles mouse ESC to EpiSC differentiation and may mimic pre-to postimplantation epiblast progression.
Rodent ground-state ESC are distinguished by and dependent on a suite of transcription factors additional to Oct4, Sox2, and NANOG . Each of these is individually dispensable due to overlapping functions in a flexible circuitry (Dunn et al., 2014) . They are absent or very lowly expressed in EpiSC and conventional human PSC. In reset cells, all are present apart from ESRRB. Absence of ESRRB is anticipated to render the ground-state circuitry more fragile ( Figure 7I) . Severe compromise to self-renewal upon KLF4 or TFCP2L1 knockdown is in line with this prediction and provides evidence that reset human PSC are functionally governed by the rewired ground-state transcription factor circuitry. Rescue of TFCP2L1 knockdown cells by ESRRB points to further functional conservation with the mouse ESC control system.
Our findings suggest that authentic ground-state pluripotent stem cells may be attainable in human, lending support to the notion of a generic naive state of pluripotency in mammals. In human, the naive-state transcription factor circuitry appears in large part to be conserved but requires greater reinforcement to be stably propagated. Disposition to collapse reflects the transient nature of naive pluripotency in the embryo ). The imperative for developmental progression may be intrinsically stronger in primates that, unlike rodents, have not evolved the facility for embryonic diapause . Nonetheless, increased number and size of colonies under conditions of transgene induction suggest that there may be scope to refine and further improve culture conditions for human ground-state PSC.
Further evaluation of the ground-state hypothesis remains necessary. Reset cells might be considered a synthetic product of genetic intervention. Seamless derivation from human epiblast is therefore a key future landmark. Formation of primary chimeras, a powerful test of naive status and developmental potency in rodents, cannot be undertaken in human. However, the finding that reset cells can consistently be incorporated into the mouse ICM/epiblast distinguishes them from conventional human PSC or mouse EpiSC and is consistent with preimplantation identity. Interestingly, upon further culture to mimic early postimplantation stages (Bedzhov and Zernicka-Goetz, 2014) , contribution of human cells to the epiblast was no longer detected.
These data are preliminary but may suggest that human cells are unable to adjust to the much faster rate and/or distinct morphogenetic organization of mouse postimplantation epiblast development. Later, contribution to same-species chimeras could be explored in nonhuman primates. Perhaps the most important question, however, at least from a translational perspective, is whether rewiring transcriptional circuitry also removes epigenetic specifications. Human genetic variation notwithstanding, epigenome status may influence consistency of both undifferentiated phenotype and differentiation behavior. Low H3K9me3 and genome-wide DNA hypomethylation point to epigenome erasure in reset cells, as in early embryos. It will be of great interest to determine the precise functional impact of such epigenetic cleansing.
EXPERIMENTAL PROCEDURES
Other procedures and reagent details are provided in the Extended Experimental Procedures.
Cell Culture
Human-embryo-derived H1, H9, and Shef6 and iPS cells were maintained in conventional PSC culture conditions with FGF/KSR on feeders.
piggyBac (PB) vectors (2 mg) carrying doxycycline-inducible KLF2 or NANOG coupled to Venus were cotransfected with an rtTA expression construct (2 mg) and pBase helper plasmid (4 mg) using the Neon Transfection System (Program 14; Invitrogen). Two days later, G418 was applied (100 mg/ml). After selection for 2 weeks, Venus-positive cells with leaky transgene expression were removed by flow cytometry. Transfectants were dissociated with trypsin and replated in the presence of Rho-associated kinase inhibitor (ROCKi) (Y-27632, Calbiochem) prior to addition of DOX (1 mM) on day 1. On day 2, medium was changed to N2B27 medium (Ndiff227, StemCells Inc.) with 1 mM PD0325901 (PD03), human LIF (prepared in house), CHIR99021 (3 mM; 2iL; 1 mM, t2iL), and DOX. Medium was changed daily. Cells were split every 5-7 days after dissociation with Accutase (Life Technologies). After 2 weeks, DOX was withdrawn and PKC inhibitor Gö 6983 added (5 mM, Sigma-Aldrich). Cells transferred to t2iL+Gö expand slowly for the initial couple of passages after withdrawal of DOX. Subsequently, cultures in t2iL+Gö were passaged every 5-7 days using Accutase. Cells were maintained on MEF feeders throughout.
For transient expression and resetting, we established H9 and Shef6 cells with a PB-EOS-GFP/puro R reporter (Hotta et al., 2009 ). This reporter is progressively silenced in conventional PSC but is re-expressed upon resetting. EOS cells were transfected with 3 mg of circular NANOG and KLF2 constitutive expression plasmids. Two days later, medium was switched to N2B27 with PD173074 (PD17, 0.5 mM), PD03 (0.5 mM), and hLIF. At day 4, cells were retransfected, and on day 8, medium was changed to t2iL+Gö . Puromycin selection (0.5 mg/ml) was applied from day 12 for two passages to enrich for EOS-expressing cells. Colonies were picked on passage 4 or 5. Presence or absence of transgene vectors was assayed by genomic PCR for the CAG promoter and TaqMan Copy Number Assays against the blasticidin resistance gene with RNase P and TERT reference assays. For colony-forming assays, we plated 1,000 cells per well in 24-well plates, 2,000 cells for 12-well plates, and 5,000 cells for 6-well plates. ROCKi was added for conventional but not reset cells.
For feeder-free culture, plates were coated overnight at 4 C with either diluted BD Matrigel hES-qualified Matrix (1:30) or Laminin 511-E8 (iMatrix-511; Nippi) at 0.5 mg/cm 2 . Cells were dissociated in the presence of ROCKi and plated in t2iL with Gö reduced to 2 mM.
Human Embryos
Human embryo research was licensed by the UK Human Fertilization and Embryology Authority. Supernumerary embryos donated from in vitro fertilization programs with informed consent were thawed and cultured to day 7 postfertilization. Blastocysts were fixed in 4% PFA, immunostained, and imaged as described (Roode et al., 2012) .
Transcriptome Meta-Analysis Sequencing reads were aligned to the human genome build hg19/GRCh37 with the STAR aligner (Dobin et al., 2013) using the two-pass method for splice junction detection (Engströ m et al., 2013) . Transcript quantification was performed with htseq-count, part of the HTSeq package (Anders et al., 2014) , using GENCODE v15 (Harrow et al., 2012) human gene annotation (Ensembl release 70) (Flicek et al., 2014) . Sequencing reads from published RNA-seq experiments were obtained from the European Nucleotide Archive (ENA). To ensure maximal compatibility between data sets, raw counts were generated in the manner described above and all RNA-seq samples were processed together. Mouse and human samples were related via one-to-one orthologous genes annotated in Ensembl v70. Libraries were corrected for total read count using the size factors computed by the Bioconductor package DESeq (Anders and Huber, 2010) and were normalized for gene length to yield FPKM values. To generate expression heatmaps, FPKM values were scaled relative to the mean expression of each gene across all samples. Heatmaps include genes for which a difference in expression was observed (i.e., scaled expression > 1 or < À1 in at least one sample). Principal components were computed by singular value decomposition with the princomp function in the R stats package, using expression levels normalized relative to the human embryo-derived PSC samples in each study. Affymetrix Human Gene Array 1.0 ST arrays were processed with the oligo Bioconductor package (Carvalho and Irizarry, 2010) to summarize probe-set transcript clusters. Microarray data from this study were normalized together with those from Gafni et al. (2013) using the robust multi-array average (RMA) method (Irizarry et al., 2003) applied through the oligo package. Principal components were calculated from the centered and scaled expression covariance matrix by singular value decomposition, computed by the prcomp function in the R stats package. Transcript clusters were associated with targeted genes based on GENCODE v15 human genome annotation (Ensembl release 70). Where multiple probe sets for a given gene were present on the array, these were summarized using the maximal expression value. Expression data for heatmaps were scaled relative to the mean expression of each gene across all samples. Affymetrix PrimeView arrays from Theunissen et al. (2014) were normalized with the RMA algorithm implemented in the affy Bioconductor package using a modified CDF environment to annotate ERCC control probes.
RNA-seq data were cross-referenced with the microarray data, restricting the analysis to the genes interrogated by each array design. To account for technical differences between experiments and platforms, expression levels were computed relative to the human embryo-derived PSC samples from each study. These values were used as the basis for global PCA and comparative analysis of marker genes.
Embryo Chimeras
Cells were stably transfected with PB-Cherry or PB-GFP reporters. Five to ten cells were aggregated with eight-cell stage mouse embryos and imaging performed 48 hr later at the expanded blastocyst stage. Alternatively, 8-12 cells were injected per blastocyst (E3.5) with imaging of hatched outgrowths 72 hr later. In some cases, outgrowths were cultured further to form egg cylinder-like rosettes (Bedzhov and Zernicka-Goetz, 2014) .
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